Norman Payson - 24 May 2023 Form 4 Insider Report for Progyny, Inc. (PGNY)

Role
Director
Signature
/s/ Mark Livingston, Attorney-in-Fact
Issuer symbol
PGNY
Transactions as of
24 May 2023
Transactions value $
$0
Form type
4
Filing time
26 May 2023, 17:07:06 UTC
Previous filing
17 Feb 2023
Next filing
28 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PGNY Common Stock Award $0 +4.39K +126.01% $0.00 7.87K 24 May 2023 Direct F1
holding PGNY Common Stock 281K 24 May 2023 See footnote F2
holding PGNY Common Stock 122K 24 May 2023 See footnote F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PGNY Stock Option (Right to Buy) Award $0 +17.7K $0.00 17.7K 24 May 2023 Common Stock 17.7K $38.24 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs shall vest on May 24, 2024, subject to the Reporting Person continuing to provide service through such date.
F2 The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust.
F3 The reportable securities are directly held by EVO Eagle, LLC. The Reporting Person shares voting and dispositive power over the securities.
F4 The shares subject to the Option shall vest on May 24, 2024, subject to the Reporting Person continuing to provide service through such date.